ABSTRACT NUMBER: ESOC2026A2162 PLASMA MMP-9 AS A PROGNOSTIC BIOMARKER IN ACUTE HEMORRHAGIC STROKE
Sardor Musayev, Gulnora Rakhimbaeva, Yulduz Musaeva, Tolibjon Khomidov · 2026
Read ABSTRACT NUMBER: ESOC2026A2162 PLASMA MMP-9 AS A PROGNOSTIC BIOMARKER IN ACUTE HEMORRHAGIC STROKE by Sardor Musayev, Gulnora Rakhimbaeva, Yulduz Musaeva, Tolibjon Khomidov (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144939.txt.
Description
Sardor Musayev and co-authors present a 2026 conference study on a blood marker in brain bleeding stroke. Hemorrhagic stroke kills and disables at high rates. Scans and intensive care improved, but early blood markers for outlook stay scarce. The enzyme MMP-9 breaks the blood-brain barrier and worsens bleeding.
Fifty patients at a Tashkent clinic were checked in the acute phase. Plasma MMP-9 levels were measured for each patient. Deficit was scored on the standard NIH stroke scale. The team tested how marker level tracks deficit scores. A firm link could give doctors a fast prognosis tool at admission.
Catalog record
| CREATOR | Sardor Musayev, Gulnora Rakhimbaeva, Yulduz Musaeva, Tolibjon Khomidov |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |